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ABSTRACT
Objective: Tailored telephone counseling and physician-
based and clinic-based interventions have been shown to
be cost-effective in enhancing utilization of mammogra-
phy among nonadherent women. The objective of this
study was to evaluate the costs and beneﬁts of a broad
implementation of these interventions from a health payer
perspective.
Methods: CAN*TROL computer modeling was em-
ployed in the cost-effectiveness analysis of interventions
in a 2000 Texas female population. The estimated effects
of the various interventions and their related costs
derived from the literature were applied to a hypotheti-
cal scenario of a broad implementation of these
interventions.
Results: Seven studies were identiﬁed from the literature,
six of them employed tailored telephone counseling (TC),
whereas two used comprehensive physician-based (PB) or
clinic-based (CB) interventions. The estimated interven-
tion cost per women was $43 for TC, $71 for PB, and
$151 for CB. CAN*TROL model showed that after
15 years of implementation, TC, PB, and CB could reduce
cancer mortality by 6.5, 2.2, and 10.7%, respectively. The
cumulative net costs of interventions, mammography
screening, and medical care costs were lower for TC (TC
vs. PB vs. CB, 1.05 million vs. 1.06 million vs. 1.60 mil-
lion). Nevertheless, CB resulted in more life-years saved
(TC vs. PB vs. CB, 11,413 vs. 8515 vs. 14,559). The incre-
mental cost-effectiveness ratio was more favorable for
tailored telephone counseling interventions. One-way
sensitivity analysis indicated that compliance rates and
intervention costs had the most signiﬁcant impact on the
incremental cost-effectiveness ratio.
Conclusion: Tailored telephone counseling interventions
may be the preferred ﬁrst-line intervention for getting
nonadherent women aged 50 to 79 years on schedule for
mammography screening.
Keywords: breast cancer screening, CAN*TROL, cost-
effectiveness analysis, mammography, tailored telephone
counseling intervention.
Introduction
Breast cancer is the most common type of malig-
nancy among women in the United States [1]. In
2002, there were an estimated 203,500 new cases of
invasive breast cancer for women in the United
States, accounting for 33% of all cancer cases in
women, with approximately 39,600 estimated
deaths [1]. The age-speciﬁc incidence rates of breast
cancer rise rapidly with age. The American Cancer
Society reports that about 1 in 249 women age 30
will develop breast cancer, and the probability of
developing breast cancer increases 6 to 10 times
among women age 50 and older [2].
The American Cancer Society recommends that
women ages 50 to 74 have mammogram screening
every 1 to 2 years, and routine mammogram
screening may reduce risk of dying from breast can-
cer by 30% [2]. Numerous provider and patient-
oriented interventions have been developed and
successfully increased the regular mammography
use over the past decade [3–8]. The 2000 Behavior-
al Risk Factor Surveillance System (BRFSS) showed
that 63% of US women age 40 and older had a
recent mammogram [9].
Nevertheless, barriers to routine mammogram
screening continue to exist among some groups of
women, especially for minority and women with
low socioeconomic status [10–14]. It has been
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reported that breast cancer mortality was higher
among African American women than white
women [15]. Lack of insurance coverage, lack of
primary care physicians, high costs of mammo-
gram, concerns about radiation, unawareness of
high breast cancer incidence, lack of education
about the utility of mammography screening, etc.,
are among some of the major reasons for noncom-
pliance [8,16–21]. Thus, research on interventions
to target women who underutilize mammography
screening has become a high priority to increase
mammogram use to 70% by the year 2010 [22].
Tailored telephone counseling interventions have
been shown to be cost-effective in enhancing
utilization of mammography among nonadherent
women in controlled clinical trials [6,23–25]. Based
on the health belief model, the transtheroretical
model, and the conﬂict model of decision making,
tailored telephone counseling interventions use
standardized protocols to identify subjects’ barriers
and provide information to overcome such barriers
[26–29]. In addition, comprehensive physician- and
clinical-based interventions have also demonstrated
some successes in increasing utilization of mam-
mography among noncompliant women in clinical
trials [30–32]. Nevertheless, whether these interven-
tions are cost-effective in a broad implementation
among noncompliant women is not well studied.
Oncology experts and health-care policy makers
generally rely on global subjective judgment to
assess the effectiveness and costs of various pro-
grams and to set priorities. Nevertheless, this
approach may yield inaccurate results owing to
oversimpliﬁcation of the complex issues. Computer
modeling can assist health-care policy makers in
analyzing various clinical and economic outcomes
using simulation of many scenarios.
CAN*TROL, a computer simulation model for
cancer control programs, was developed by Dr
David Eddy and the National Cancer Institute
(NCI) in the early 1990s [33–35]. It has been used
in the United States, Norway, Israel, Chile, India,
and many other countries to project population-
based cancer rates up to 40 years as well as to assess
the cost-effectiveness of different cancer screening,
intervention, and control programs.
In this study, we reviewed and compiled recent
studies on tailored telephone counseling and
comprehensive physician-based and clinic-based
intervention programs to enhance mammography
screening among noncompliant women. The esti-
mated effects of the interventions and their related
costs derived from the literature review were then
applied to a hypothetical scenario of a broad imple-
mentation of interventions using CAN*TROL
computer modeling. The purpose was to project
population-based cancer mortality over time as well
as to compare the incremental cost-effectiveness (C/
E) ratios for tailored telephone counseling and phy-
sician-based and clinic-based intervention programs
from a health payer perspective.
One-way sensitivity analysis was also performed
to identify key cost and effect parameters that may
require additional primary data collection to reduce
the level of uncertainty. An upper and lower bound
on the possible ranges of estimates was set for base-
line compliance rates, mammography screening
costs, intervention costs, false-positive rates for
screening, costs for diagnostic workup, postinter-
vention compliance rates, and discount rates.
Methods
The 2000 Texas female population age 50 to 79 was
used in a hypothetical scenario for a broad im-
plementation of the interventions for the cost-
effectiveness analysis [36]. The intervention
programs were applied to women ages 50 to 79,
who were nonadherent to mammography screen-
ing. The percentage of nonadherent women was
estimated from the Behavioral Risk Factor Surveil-
lance System [9]. The control group was the usual
care, where printed letters are commonly employed
as reminders for mammography screening.
The CAN*TROL model was employed to eval-
uate the cost-effectiveness of intervention programs.
In CAN*TROL, persons are assigned to 1 of the
109 states, consisting of a healthy state, 105 cancer
states, a cured state, a dead of cancer state, and a
dead of other causes state. Within each state there
are 100 one-year age groups that keep track of indi-
viduals by age. During each annual cycle, an indi-
vidual may remain in a given state or shift to
another state according to transition probabilities.
Each run of the CAN*TROL model requires three
types of input: population data, cancer data, and
session information. The session speciﬁes the pop-
ulation and cancer data ﬁles to be used for cancer
control programs.
The cancer information used in CAN*TROL for
baseline prevalence cases, incidence rates, stage
distribution, and stage-speciﬁc survival curves of
breast cancer were obtained from Surveillance, Epi-
demiology, and End Results (SEER) [37]. The TNM
staging system was used for breast cancer staging
[1].
A literature search in the MEDLINE, CancerLit,
EmBase, HealthStar, and International Pharmaceu-
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tical Abstracts database was performed to iden-
tify studies using “mammogram,” “breast cancer
screening,” “intervention,” “telephone coun-
seling,” “physician-based,” “clinic-based,” and
“cost-effectiveness” as key words. Because there
were a number of meta-analysis and review articles
already completed in the late 1990s, the current lit-
erature review focused primarily on the publica-
tions for 1999 to 2002 [3,38–40]. Studies were
reviewed for study designs, study settings, popula-
tions involved, age of the subjects, intervention pro-
grams used, mammography compliance rates, and
related cost information. Studies not based in the
United States were excluded owing to the lack of
generalizability to the U.S. health-care system. Stud-
ies that employed tailored telephone counseling
or physician-based or clinic-based interventions
among noncompliant women age 50 and older were
included in the study.
The identiﬁed studies were grouped into three
categories: tailored telephone counseling and
physician-based and clinic-based interventions for
cost-effectiveness analysis. The effects of the inter-
ventions varied by different study settings and char-
acteristics of study participants, such as ethnicity,
socioeconomic status, education level, venue where
study was conducted, recruitment and follow-up
procedures, combination of multiple interventions,
etc. Thus, summary statistics using Mantel-
Haenszel test were not computed owing to hetero-
geneity of these studies. Nevertheless, the mean and
possible ranges of compliance rates and associated
costs were obtained from studies with similar inter-
vention programs. The estimated effects and costs
were then applied to the hypothetical scenario for
the cost-effectiveness analysis.
Costs were estimated from a health payer per-
spective. The cost information used in CAN*TROL
included intervention, screening, and treatment
costs. Intervention costs included ﬁxed and variable
costs for interviewer/counselor recruitments, train-
ings, meetings, preintervention assessments, printed
materials, telephone charges, computer systems,
and other infrastructure costs. Research costs such
as baseline and follow-up surveys and the develop-
ment costs of the telephone scripts were not
included. Screening program costs included mam-
mography screening costs and costs for false-posi-
tive screening tests. Treatment costs included the
costs for initial care and continuing care for various
stages of the disease. The assumptions made for the
CAN*TROL model are:
• The screening period was from 2000 to 2015.
• Forty-one percent of Texas women ages 50 to
79 who were not compliant to mammogram
screening were included in the model [9].
• The expected changes for stage-speciﬁc propor-
tions of breast cancer cases as results of the
intervention programs were estimated [41].
• The average false-positive rate in numbers of
mammograms performed was assumed 8%
[42,43].
• The discount rate of 0.03 was used [44].
• Cost information obtained from the literature
was converted to 2000 U.S. dollars using con-
sumer price index for medical services [45].
The average C/E ratio was deﬁned as cumulative
net cost divided by total life-years saved. It was
computed for usual care, telephone counseling, and
physician-based and clinic-based interventions to
show the average cost of gaining life-years under
the policy alternative. The incremental C/E ratio
was computed in a stepwise fashion to compare
each alternative by moving up the program inten-
sity step by step. For instance, telephone coun-
seling was compared with usual care using the
formula
incremental C/E ratio = (cumulative net costs for 
telephone counseling - cumulative net costs for 
usual care)/(total life-years saved for telephone 
counseling - total life-years saved for usual care).
(1)
Clinic-based intervention was compared with tele-
phone counseling. The incremental C/E ratio was
computed for two scenarios where the interventions
were implemented every year and every 2 years for
annual mammogram screening.
Sensitivity analysis was conducted using one-way
analysis for the uncertain parameters. An upper and
lower bound on the possible ranges of estimates for
baseline compliance rates, intervention costs, mam-
mography screening costs, false-positive rates of
screening, diagnostic workup, postintervention
compliance rates, and discount rates was set as fol-
lows based on expert opinion and the literature
[42–49]:
• Baseline compliance rate, 18% to 41%;
• Intervention cost, $13 to $88;
• Mammography screening cost, $80 to $120;
• False-positive rate of screening, 6.5% to 10%;
• Cost for diagnostic workup, $257 to $718;
• Postintervention compliance rate, 22% 60%;
and
• Discount rate, 0% to 5%.
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Results
Table 1 summarizes the 7 studies identiﬁed
[25,30,32,50–55]. These studies targeted noncom-
pliant women age 50 and older in the United States.
All studies were randomized controlled clinical tri-
als with sample size ranging from 196 to 1765.
Among these studies, except for one study that was
conducted in community churches, all others were
carried out in HMOs, public hospitals, or commu-
nity clinics. All studies used self-reported mammog-
raphy screening status as outcomes of interest, and
the period of observation for the effect of interven-
tion programs was 12 month for most studies.
Six studies employed tailored telephone coun-
seling interventions whereas two employed compre-
hensive physician-based or clinic-based programs.
Descriptions of interventions employed in each
study and associated effectiveness and costs are pre-
sented in Table 2. In general, for tailored telephone
counseling interventions, trained telephone coun-
selors followed the standardized protocols to iden-
tify women’s barriers for regular mammogram
screening and provide counseling to overcome
the barriers. Professional counselors, departmental
staffs, or graduate nurse research assistants may
perform tailored telephone counseling. The compre-
hensive physician and ofﬁce system interventions
included physician training programs on mammog-
raphy counseling skills, monetary incentives of
$150 to physicians who participated in the training
programs, and videos and complimentary ofﬁce
workshops for ofﬁce staff to improve tracking of
mammography screening. The clinic-based inter-
ventions with tailored counseling and reminder call
included research nurses highlighting the charts of
noncompliant women to remind physicians speak-
ing to the woman about mammography screening;
women receiving nurse prompts and barrier-speciﬁc
counseling at clinics were also encouraged to watch
videos designed to motivate screening; and nurses
making reminder calls to women a few days before
Table 1 Recent publications on various types of  interventions to enhance mammography compliance
First author
(sample size)
Year published
(study period)
Age range
(years)
Mammography
use
Study
setting Interventions
Effectiveness Temp.*
(%)
Costs 
(per woman)
Rimer [50]
(n = 1091)
2002
(12 months)
50 + Noncompliant (off
schedule in
previous year)
HMOs, North
Carolina
Usual care
Tailored print (TP)
TP plus tailored
phone counseling
18
13
22
NA
Thompson [30]
(n = 196)
2002
(8 weeks)
50–74 Noncompliant Public
hospitals, 
Washington
Usual care
Clinic-based
intervention with
tailored
counseling and 
reminder call
22
49
—
$151.00
(1996)
Costanza [32]
(n = 1027)
2000
(12 months)
50–80 Noncompliant
(never/former 
user before 
24 months)
HMOs,
Massachusetts
Usual care
Tailored telephone
counseling
Physician-based
plus ofﬁce 
system
30
35
34
—
$43.03
$71.64
Lipkus [25]
(n = 286)
2000
(12 months)
50+ Noncompliant
(off  schedule 
in previous
year)
HMOs, North
Carolina
Usual care
Tailored brochure
Tailored telephone
counseling
41
39
60
—
$88.21
$88.16
Stockdale [51]
(n = 291)
2000
(12 months)
50–80 Noncompliant Community
churches, 
California
Usual care
Tailored telephone
counseling
63
65
—
$28.20
(1997)
Taplin [53]
(n = 1765)
2000
(12 months)
50–79 Noncompliant
(never/former 
user before 
2 months)
HMOs,
Washington 
Usual care
Reminder call
Motivational call
35
52
50
—
$21.22
$25.99
(1998)
Saywell [55]
(n = 808)
1999
(4–6 weeks)
50–85 Noncompliant
(off  schedule in
last 15 months) 
HMOs, Indiana Usual care
Tailored in-person
counseling
Tailored telephone
plus letter
Tailored in-person
plus letter
18
34
36
31
—
$14.21
$13.58
$18.03
*Refer to mammography compliance rate.
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their mammogram appointments. The study by
Stockdale et al. [51] that was conducted in commu-
nity churches was not included in the analysis and
was being discussed separately.
The average baseline compliance rate among
noncompliant women was 27.3% with a range of
18% to 41%. The estimated effects of tailored tel-
ephone counseling interventions ranged from 22%
to 60% (mean 40.6%) and the effect of physician-
based and clinic-based interventions was 34 and
49%, respectively. There were six studies that pro-
vided cost information. For tailored telephone
counseling interventions, the estimated costs per
women receiving interventions varied from $13.58
to $88.16 (average $42.69). The variations in cost
estimates were due to reported years (only one
study speciﬁed the year), study sample size (e.g.,
intervention costs, particularly start-up costs,
divided by a small number of participants resulted
in higher per person costs), payer or societal per-
spectives, inclusion of indirect costs, indirect cost
rates allocated to the interventions, personnel
involved in counseling (e.g., trained counselors or
research assistants), or counseling time. Only the
study by Costanza et al. [32] included indirect costs
where an indirect cost rate of 56% was applied to
the total costs to estimate facilities and other infra-
structure costs (e.g., personnel beneﬁts, heat, light,
and space). In addition, Costanza et al. found that
the estimated costs per women for tailored tele-
phone counseling were similar between HMO and
societal perspectives (HMO vs. societal perspective
$43.03 vs. $45.38). The estimated costs per women
for the physician-based plus ofﬁce systems were
much higher from societal perspectives than HMO
perspectives (HMO vs. societal perspective $71.64
vs. $132.67). The clinic-based interventions with
tailored counseling and reminder call were most
costly: $151 from the societal perspective. Similar
to physician-based interventions, higher percent-
ages of costs in clinic-based interventions were due
to physician time spent in training and meetings; the
costs per woman from HMO perspective were
much less than from societal perspective. Ninety
dollars per woman was assumed for clinic-based
interventions from HMO perspective.
The estimated effects and related costs for the tai-
lored telephone counseling and physician-based and
clinic-based interventions were then applied to
CAN*TROL computer modeling to project total
cancer mortality over 15 years as well as to com-
pare the cost-effectiveness ratio of a broad imple-
mentation of the interventions.
Table 3 shows the 2000 Texas female popula-
tions by different age groups, and 41% of them
were used in the CAN*TROL model. The costs for
Table 2 Tailored telephone counseling and physician-based and clinic-based interventions
First author
(sample size)
Interventions (adopted
from the original articles)
Effectiveness 
(mammogram
compliance, %)
Costs 
(per woman)
Tailored telephone counseling
Rimer [50]
(n = 1091)
Professional telephone interviewers interviewed women and average 
interview length was 29 min.
22% NA
Costanza [32]
(n = 1027)
Counselors used a standardized protocol, identiﬁed the subject’s barriers, and 
then provided information to address and overcome the barriers. The 
average duration of  counseling was 5.5 min.
35% $43.03
Lipkus [25]
(n = 286)
Women were called by a trained female telephone counselor who followed a 
scripted computer-based protocol to reinforce previous screening.
60% $88.16 (societal 
perspective, no
indirect cost)
Taplin [53] [56]
(n = 1765)
A scheduler who was employed within one radiology department conducted 
counseling about participation in screening and scheduled appointments
50% $25.99 (1998) (no
indirect cost)
Saywell [55]
(n = 808)
Graduate nurse research assistants conducted the telephone counseling
sessions using tailored counseling protocols
36% $13.58 (no 
indirect costs)
Clinic-based or physician-based interventions
Thompson [30]
(n = 196)
Clinic-based interventions with tailored counseling and reminder call:
Research nurses highlighted the charts of  noncompliant women to remind
physicians speaking to the woman about mammography screening. 
The women received nurse prompts and barrier-speciﬁc counseling at 
clinics and were also encouraged to watch videos designed to motivate 
screening. The nurses made reminder calls to women a few days before 
their mammogram appointments.
49% $151.00 (1996)
(societal 
perspective)
Costanza [32]
(n = 1027)
Physician-based plus ofﬁce system including physician training programs on
mammography counseling skills, monetary incentives of  $150 to physicians
who participated in the training programs, videos, and complimentary ofﬁce 
workshops for ofﬁce staff  to improve tracking of  mammography screening
34% $71.64 (HMO 
perspective); 
$132.67 
(societal
perspective)
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mammography screening, diagnostic workup, and
breast cancer treatment in various cancer stages
were also listed in detail in this table.
Figure 1 depicts the cancer mortality rate over
15 years for tailored telephone counseling and phy-
sician-based and clinic-based interventions, com-
pared to usual care from CAN*TROL (tailored
telephone counseling 28.32/100,000; physician-
based intervention 29.61/100,000; clinic-based
intervention 27.06/100,000; usual care 30.29/
100,000). Compared to usual care, tailored tele-
phone counseling and physician-based and clinic-
based interventions reduced the cancer mortality by
6.5, 2.2, and 10.7%, respectively.
Table 4 presents the results for the cost-
effectiveness analysis of mammography interven-
tions from CAN*TROL computer modeling. The
CAN*TROL model indicated that cumulative net
costs were $1.05 million, $1.06 million, and $1.60
million for tailored telephone counseling and phy-
sician-based and clinic-based interventions, respec-
tively, compared to $0.54 million for usual care.
Tailored telephone counseling and physician-based
and clinic-based interventions resulted in an addi-
tional 11,413, 8,515, and 14,559 life-years, respec-
tively, compared to an additional 5,602 life-years
for usual care.
The average cost of gaining life-years for tailored
telephone counseling was the lowest among the four
policy alternatives (cost-effectiveness ratio, tailored
telephone counseling vs. physician-based interven-
tion vs. clinic-based intervention vs. usual care
92,270 vs. 124,490 vs. 109,700 vs. 96,160). Tai-
lored telephone counseling and clinic-based inter-
ventions were selected for the stepwise computation
method. It showed that the incremental C/E ratio
Table 3 Values (in 2000 dollars) used in the CAN*TROL
model for cost-effectiveness analysis of  intervention programs
Age group (years) Texas female population
50–54 607,197 (26%)
55–59 460,416 (20%)
60–64 366,974 (16%)
65–69 326,915 (14%)
70–74 297,211 (13%)
75–79 248,697 (11%)
Total  2,307,410
Breast cancer Costs (per woman)
Mammography screening $100
Diagnostic workup $556
False-positive rate of  screening 8%
Initial treatment for stage 0 $11,444
Initial treatment for stage 1 $13,897
Initial treatment for stage 2 $16,186
Initial treatment for stage 3 $16,186
Initial treatment for stage 4 $19,619
Continuing treatment for stage 0 $1,226
Continuing treatment for stage 1 $1,226
Continuing treatment for stage 2 $1,635
Continuing treatment for stage 3 $1,635
Continuing treatment for stage 4 $3,924
Cancer terminal care $24,524
Other terminal care $16,349
Figure 1 Cancer Mortality Rates for All Ages (per 100,000) from
2000 to 2015. Usual care, using reminder letters to enhance mam-
mography screening; telephone counseling intervention, using tailored
telephone counseling interventions plus reminder letters to enhance
mammography screening; physician-based intervention, using
physician-based interventions plus ofﬁce systems and reminder letters
to enhance mammography screening; and clinic-based intervention,
using comprehensive clinic-based interventions plus tailored coun-
seling and reminder letters to enhance mammography screening.
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Table 4 Cost-effectiveness, (in 2000 dollars) in of  screening mammography interventions
Strategy
Cost* ($,
in 1000s)
Incremental
cost
($, in 1000) Effect†
Incremental
effect
Cost-
effectiveness ($)
Incremental 
cost- 
effectiveness ($)
(A) Intervention implemented every year
Usual care 538,691 — 5,602 — 96,160 —
Telephone counseling 1053,085 514,394 11,413 5,811 92,270 88,520
Clinic-based intervention 1597,207 544,122 14,559 3,146 109,700 172,960
(B) Intervention implemented every two years
Usual care 538,691 — 5,602 — 96,160 —
Telephone counseling‡ 890,389 351,698 9,580 3,978 92,940 88,410
Clinic-based intervention§ 1274,828 384,439 13,950 4,370 91,380 87,970
*Including intervention costs, costs for mammography screening, and medical care costs from 2000 to 2015.
†Refer to life-years saved.
‡Assume 37% compliance rate
§Assume 47% compliance rate.
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was more favorable for tailored telephone coun-
seling interventions (tailored telephone counseling
vs. clinic-based intervention 88,520 vs. 172,960).
Comparing the scenarios of implementing the inter-
ventions every year or every 2 years, assuming the
average compliance rates in a biannual scenario
were 37% (90% of the compliance rates in an
annual scenario), implementing tailored telephone
counseling interventions every 2 years was as cost-
effective as implementing every year. In addition,
clinic-based interventions could be as cost-effective
as tailored telephone counseling programs if aver-
age compliance rates in a biannual scenario were
about 47% (95% of the compliance rates in an
annual scenario).
Results of one-way sensitivity analyses for seven
variables that may affect the incremental cost-effec-
tiveness ratio are shown in Fig. 2. The tailored tel-
ephone counseling interventions were used as the
baseline case (incremental C/E: 88,520). Varying the
compliance rates, or stage-speciﬁc proportions, had
the most signiﬁcant impact on the results. The com-
pliance rate set at 60% resulted in $18,750 decrease
in the incremental C/E ratio. Varying the interven-
tion costs also had a signiﬁcant impact on the
results. For instance, using an intervention cost of
$88 would result in a $56,120 increase in the incre-
mental C/E ratio. Varying the baseline compliance
rates had a moderate impact on the results. On the
other hand, varying the discount rates, percentage
of false-positive rates, mammogram costs, and costs
for diagnostic workup had only a small impact on
the results.
Discussion
The current review and analysis showed that
tailored telephone counseling interventions were
more cost-effective than physician-based and
clinic-based interventions if a broad implementa-
tion to enhance mammography compliance were to
be adopted. Clinic-based interventions were more
costly than tailored telephone counseling owing to
the higher costs incurred from multiple strategies
(e.g., physician trainings, meetings, tailored coun-
seling, and reminder calls). Although clinic-based
interventions could achieve a higher compliance
rate, the overall incremental cost-effectiveness ratio
was more favorable for tailored telephone coun-
seling programs.
Physician-based interventions had the effect
lower than tailored telephone counseling programs.
In addition, costs associated with physician training
and meetings are generally higher than costs for
counselors or nurses in tailored telephone coun-
seling programs; physician-based interventions had
the higher average cost of gaining life-years than tai-
lored telephone counseling programs. Costanza et
al. [32] also found that tailored telephone coun-
seling programs were more cost-effective than phy-
sician-based educational interventions in enhancing
mammography utilization among underusers of
mammography [32]. They found tailored telephone
counseling interventions were three times as expen-
sive as the usual care, but physician-based educa-
tional interventions were ﬁve times as expensive.
Furthermore, physician-based education interven-
tions were much more expensive from a societal
perspective than from a health payer perspective.
Implementing tailored telephone counseling
interventions every 2 years would be as cost-
effective as implementing every year if average
mammography compliance rates in a biannual sce-
nario were about 37% (90% of the compliance
rates in an annual scenario). Furthermore, if inter-
ventions were implemented every 2 years, clinic-
based interventions could be as cost-effective as tai-
lored telephone counseling programs if average
compliance rates were about 47% (95% of the
compliance rates in an annual scenario).
Our sensitivity analysis suggested that varying
the compliance rates, or stage-speciﬁc proportions,
had the most signiﬁcant impact on the incremental
C/E ratio. Changing the compliance rates inﬂuenced
both the numerator and the denominator of the
incremental C/E ratio. Increasing utilization of
mammography screening could result in a reduction
of the overall costs because a high percentage of
women would be diagnosed with breast cancer in
an earlier stage. This would decrease the number of
Figure 2 Sensitivity analysis for tailored telephone counseling inter-
vention. Sensitivity analysis was conducted for tailored telephone
counseling interventions (incremental C/E ratio 88,520 was used as
baseline). Changes in the incremental C/E ratio as a result of  changing
each variable are presented. For instance, increasing compliance rate
to 60% would result in $18,750 decrease in the incremental C/E ratio.
-9,120 3,9900
-7,160 3,860
-38,070 6,5 120
-18,750
99,890
-3,950 1,416
-8,240 14,630
-2,770 39,210
-80,000 -40,000 0 40,000 80,000 120,000
change in C/E ratio 
Discount rate (0-5%)
Mammogram cost ($80-120)
Intervention cost ($13-88)
Compliance rate (22-60%)
False positive rate (6.5-10%)
Diagnostic workup ($257-718)
Baseline compliance rate (18-41%)
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women developing advanced diseases that would
require more extensive cancer treatments. In addi-
tion, early diagnosis also signiﬁcantly reduces over-
all cancer mortality and increases the number of
lives saved.
Varying the intervention costs also had a signiﬁ-
cant impact on the results. The estimated costs of
the interventions varied by study. The differences
in estimates are likely attributed to reported years,
study sample size, whether there was preinterven-
tion assessment, different methods used to measure
time required for staff training and meetings, inclu-
sion of indirect costs, indirect cost rates allocated to
the interventions, personnel involved in counseling
(e.g., trained counselors, or research assistants), or
counseling time. In addition, ongoing costs of inter-
ventions may be lower than start-up costs as staff
training costs may be needed only at the beginning
of the program. Unfortunately, we did not ﬁnd any
studies specifying the initial and ongoing costs for
the cost-effectiveness analysis. Future research may
require additional primary data collection for initial
and ongoing costs of the interventions.
In many HMOs, reminder letters have already
been established as a standard of care as mammo-
gram screening reminder; however, better reminder
systems are still needed to target nonadherent
women, especially for minority and women with
low socioeconomic status. The current study sug-
gests that tailored telephone counseling interven-
tions may be the preferred ﬁrst-line intervention for
getting nonadherent women age 50 to 79 on sched-
ule for mammography screening from a health
payer perspective. Tailored telephone counseling
interventions are customized toward addressing
individual subject’s circumstance, especially in
regard to speciﬁc screening and risk status of these
women (e.g., concerns about radiation, unaware-
ness of high breast cancer incidence). These factors
generally are similar to other common study varia-
bles for health behavior theories such as the trans-
theoretical model and the HBM. With an adequate
behavioral theory as support, tailored telephone
counseling programs appear to be the most prom-
ising interventions for nonadherent women.
Taplin et al. [53] compared reminder telephone
call and motivational telephone call interventions to
increase mammography screening in a randomized
trial among women ages 50 to 79. They found that
the reminder calls was as effective as motivation
calls (HR .97, 95% CI 0.8–1.2). Motivational call
was more costly than simple reminder call, although
the difference between these two telephone inter-
ventions was small (reminder call vs. motivational
call $21.22 vs. $25.99) [54]. Simple calling and
reminding may be as important as tailored tele-
phone counseling. Further research comparing these
two telephone interventions is needed to conﬁrm
their ﬁndings.
There are some limitations in the study. The
CAN*TROL model is designed to predict average
costs and beneﬁts resulting from cancer control
programs from a population perspective. Thus,
CAN*TROL could not be used to predict the ef-
fects for individuals, who are likely to have differ-
ent compliance of mammography. In addition,
CAN*TROL requires direct data input for the
expected changes for stage-speciﬁc proportions of
breast cancer cases as results of the interventions.
Other computer modeling may be developed to
include mammography compliance rates as direct
data input. Furthermore, the studies by Costanza et
al. [32] and Taplin et al. [53] showed that the inter-
ventions on former users were more effective than
never users [32,53]. Other computer modeling
could be developed to differentiate the effects of
interventions in these two groups. Also, the current
model was based on false-positive rates in numbers
of mammograms performed to estimate the average
costs for false-positive workup. Other computer
modeling for the false-positive rates among women
who have mammography screening could be further
developed to account for various factors affecting
false-positive rates, such as age of women and ﬁrst
or subsequent mammograms.
In addition, the current study was carried out
under the assumption that mammography has been
established as a cost-effective tool with high sensi-
tivity in breast cancer screening among women ages
50 to 79. There are controversies about whether
mammography screening truly reduces breast cancer
mortality [56]. Finally, CAN*TROL does not
explicitly account for the changes in “lead time.” In
other words, survival may improve in screening pro-
grams just because the time of diagnosis is earlier
than it would have been without screening. Never-
theless, the time of death may remain unchanged.
There are several directions that future research-
ers in this ﬁeld could consider. First, the cost-
effectiveness of intervention programs could be
evaluated from a societal perspective, which could
incorporate indirect costs related to intervention
programs, mammography screening and cancer
treatments (e.g., personal time and family care
time). Second, interventions implemented through
churches may be a promising community-based
strategy, especially to target minority women. David
et al. [57] indicated that more than 61% of women
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ages 50 to 80 attend church at least once per month.
Attending church is generally viewed as important
community resources and social support networks
for delivering health promotion projects. Third,
cost-utility analysis may be performed to evaluate
the impact of the intervention programs and mam-
mography screening on quality of life and the
attainable mortality reduction.
Conclusions
The CAN*TROL model indicated that after a
broad implementation of the interventions for
15 years, tailored telephone counseling and physi-
cian-based and clinic-based interventions could
reduce cancer mortality by 6.5, 2.2, and 10.7%,
respectively, compared to the usual care. The cumu-
lative net costs including interventions, mammogra-
phy screening, and medical care costs were $1.05
million for tailored telephone counseling, $1.06
million for physician-based, and $1.60 million for
clinic-based interventions. The tailored telephone
counseling and physician-based and clinic-based
interventions resulted in an additional 11,413,
8,515, and 14,559 life-years, respectively. The
incremental cost-effectiveness ratio was more favo-
rable for tailored telephone counseling programs.
Varying the compliance rate, or stage-speciﬁc pro-
portions, and intervention costs had the most
signiﬁcant impact on the incremental C/E ratios.
Overall, tailored telephone counseling interventions
may be the preferred ﬁrst-line intervention for get-
ting nonadherent women ages 50 to 79 on schedule
for mammography screening from a health payer
perspective.
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